跳至主要内容
临床试验/NCT06029504
NCT06029504招募中不适用

Optical Guided Sentinel Node Biopsy for Staging of Vulvar Cancer

Rigshospitalet, Denmark1 个研究点 分布在 1 个国家目标入组 115 人开始时间: 2023年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
115
试验地点
1
主要终点
Sentinel Node detection rate

研究概览

简要总结

The aim of this study is to investigate whether Sentinel Node biopsy can be performed without the use of lymphoscintigraphy and with ICG as a mono-tracer in women with vulvar cancer, unifocal tumor < 4 cm (clinical stage IB and II). Further, to investigate the accuracy of combined PET-CT and ultrasound (US) of the groins with US-guided biopsy of suspicious lymph nodes for the identification of macro-metastases in women with vulvar cancer, unifocal tumor < 4 cm.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients with primary vulva cancer, FIGO stage IB (tumor < 4 cm)
  • Patients with unifocal recurrence in the vulva (tumor < 4 cm) located on the side where the patient is surgically naïve in the groin

排除标准

  • Prior irradiation of the vulva or groins
  • Prior SNB or inguinal lymphadenectomy in the relevant groin
  • Known allergy to ICG or iodine (ICG contains 5% sodium iodine)

结局指标

主要结局

Sentinel Node detection rate

时间窗: Three years

SN detection rate with ICG and 99mTc-Nanocoll alone perioperatively, where lymphoscintigraphy is blinded, in patients with vulvar cancer (tumor \< 4 cm) without clinical suspicion of metastases to the inguinal lymph nodes.

次要结局

  • Sensitivity, specificity, PPV and NPV(Three years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ligita Paskeviciute Froding

Principal Investigator

Rigshospitalet, Denmark

研究点 (1)

Loading locations...

相似试验